Your browser doesn't support javascript.
loading
Stabilized Peptide HDAC Inhibitors Derived from HDAC1 Substrate H3K56 for the Treatment of Cancer Stem-Like Cells In Vivo.
Wang, Dongyuan; Li, Wenjun; Zhao, Rongtong; Chen, Longjian; Liu, Na; Tian, Yuan; Zhao, Hui; Xie, Mingsheng; Lu, Fei; Fang, Qi; Liang, Wei; Yin, Feng; Li, Zigang.
Afiliación
  • Wang D; School of Chemical Biology and Biotechnology, Peking University Shenzhen Graduate School; State Key Laboratory of Chemical Oncogenomics, Key Laboratory of Chemical Genomics, Peking University Shenzhen Graduate School, Shenzhen, China.
  • Li W; School of Chemical Biology and Biotechnology, Peking University Shenzhen Graduate School; State Key Laboratory of Chemical Oncogenomics, Key Laboratory of Chemical Genomics, Peking University Shenzhen Graduate School, Shenzhen, China.
  • Zhao R; School of Chemical Biology and Biotechnology, Peking University Shenzhen Graduate School; State Key Laboratory of Chemical Oncogenomics, Key Laboratory of Chemical Genomics, Peking University Shenzhen Graduate School, Shenzhen, China.
  • Chen L; School of Chemical Biology and Biotechnology, Peking University Shenzhen Graduate School; State Key Laboratory of Chemical Oncogenomics, Key Laboratory of Chemical Genomics, Peking University Shenzhen Graduate School, Shenzhen, China.
  • Liu N; School of Chemical Biology and Biotechnology, Peking University Shenzhen Graduate School; State Key Laboratory of Chemical Oncogenomics, Key Laboratory of Chemical Genomics, Peking University Shenzhen Graduate School, Shenzhen, China.
  • Tian Y; School of Life Science and Engineering, Southwest Jiaotong University, Chengdu, China.
  • Zhao H; Division of Life Science, Clarivate Analytics, Beijing, China.
  • Xie M; School of Chemical Biology and Biotechnology, Peking University Shenzhen Graduate School; State Key Laboratory of Chemical Oncogenomics, Key Laboratory of Chemical Genomics, Peking University Shenzhen Graduate School, Shenzhen, China.
  • Lu F; School of Chemical Biology and Biotechnology, Peking University Shenzhen Graduate School; State Key Laboratory of Chemical Oncogenomics, Key Laboratory of Chemical Genomics, Peking University Shenzhen Graduate School, Shenzhen, China.
  • Fang Q; School of Chemical Biology and Biotechnology, Peking University Shenzhen Graduate School; State Key Laboratory of Chemical Oncogenomics, Key Laboratory of Chemical Genomics, Peking University Shenzhen Graduate School, Shenzhen, China.
  • Liang W; Department of Radiation Oncology, The First Affiliated Hospital, Anhui Medical University, Hefei, China.
  • Yin F; School of Chemical Biology and Biotechnology, Peking University Shenzhen Graduate School; State Key Laboratory of Chemical Oncogenomics, Key Laboratory of Chemical Genomics, Peking University Shenzhen Graduate School, Shenzhen, China. lizg@pkusz.edu.cn yinfeng@pkusz.edu.cn.
  • Li Z; School of Chemical Biology and Biotechnology, Peking University Shenzhen Graduate School; State Key Laboratory of Chemical Oncogenomics, Key Laboratory of Chemical Genomics, Peking University Shenzhen Graduate School, Shenzhen, China. lizg@pkusz.edu.cn yinfeng@pkusz.edu.cn.
Cancer Res ; 79(8): 1769-1783, 2019 04 15.
Article en En | MEDLINE | ID: mdl-30842103
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Fragmentos de Péptidos / Células Madre Neoplásicas / Histonas / Histona Desacetilasa 1 / Inhibidores de Histona Desacetilasas / Lisina / Neoplasias Límite: Animals / Female / Humans Idioma: En Revista: Cancer Res Año: 2019 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Fragmentos de Péptidos / Células Madre Neoplásicas / Histonas / Histona Desacetilasa 1 / Inhibidores de Histona Desacetilasas / Lisina / Neoplasias Límite: Animals / Female / Humans Idioma: En Revista: Cancer Res Año: 2019 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos